📢 The U.S. FDA launched a new program - the Commissioner’s National Priority Voucher (CNPV) - to shorten review timelines from 10-12 months to 1-2 months following a sponsor’s final drug application submission. ⭐ The vouchers will be given only to the companies that are aligned with U.S. national priorities. ⭐ Attached is the slide deck with additional details. 📧 For further details, please write to us at support@oncofocus.com. 🌐 References: 1) https://www.fda.gov/news-eve